SS-31 10mg

Researchers comparing SS-31 10mg suppliers should evaluate the exact product record, the released-lot documentation, and the analytical methods reported for that lot. Pure Lab Peptides supplies SS-31 10mg as a lyophilized research material strictly for in-vitro laboratory research. It is not intended for human or veterinary use, ingestion, injection, or any form of administration.

SS-31 10mg Product Record

SS-31 is a synthetic tetrapeptide discussed in mitochondrial and cardiolipin-related research literature. It is also referenced in scientific sources by names including elamipretide and MTP-131. Those names provide literature context, but they do not replace the product label or the lot-specific analytical record.

On this page, 10mg is the labeled content of the vial. It is a catalog specification, not a protocol, dose, concentration, or recommendation for any experiment. The product title, labeled content, lot number, physical form, and COA should agree before the material is accepted into a research inventory.

Independent Testing and COA Review

Every released production lot is independently tested. The final image in this product gallery provides the lot-specific Certificate of Analysis summary and a QR code or link to the original third-party laboratory report. The summary identifies the lot, test date, report number, applicable methods, and selected results.

The Pure Lab Peptides-branded summary is a readable presentation of selected fields from the independent source report. It is not a substitute for the original report. The linked source should be consulted for the full method record, signatories, and laboratory-specific limitations.

Read each analytical result for the question it answers

• Chromatographic purity describes the relative chromatographic signal under the stated method and conditions. It is not a measurement of the peptide amount in milligrams.
• Identity testing evaluates whether the analytical evidence is consistent with the expected peptide. A recorded powder mass is a different measurement and does not, by itself, establish peptide identity.
• Content or assay results, when reported, must be interpreted using the method named in the laboratory report. A labeled vial amount is not itself proof of a measured peptide content.

These results are related but not interchangeable. A purity percentage alone should not be interpreted as proof of identity, mass, or labeled content. Analytical guidance from FDA, ICH, ISO, and NIST emphasizes method suitability, traceability, and clear reporting of what a procedure actually measures.

Comparing 10mg, 30mg, and 50mg SS-31

The 10mg, 30mg, and 50mg SS-31 listings belong to the same product family, but each strength is a distinct commercial product record. The selector on the purchase panel makes it easy to move among available strengths; it does not make their vial labels, inventory, lots, or COAs interchangeable.

For the 10mg listing, review the documentation attached to this exact page and current production lot. Do not use the analytical record for a different strength as a substitute. The labeled content and lot number determine which analytical record is relevant to the vial being reviewed.

Laboratory Procurement Checklist

A technical review of SS-31 10mg should confirm:

• the listing and vial label identify SS-31 and the 10mg labeled content;
• the material is clearly labeled for research use only;
• the COA is tied to a specific lot and report date;
• the vial lot matches the lot shown in the summary and source report;
• purity, identity or mass-related testing, and labeled-content results are distinguished correctly;
• the original third-party report is available through the provided QR code or link;
• the physical form and documented storage conditions agree with receiving records; and
• any comparison with 30mg or 50mg uses the corresponding product and lot documentation.

Research Literature Context

Peer-reviewed publications discuss SS-31 in relation to mitochondrial membranes, cardiolipin interactions, electron transport, and cellular bioenergetics. For example, Mitchell and colleagues studied lipid-bilayer binding and surface electrostatics, while Chavez and colleagues mapped mitochondrial protein interactions using chemical cross-linking and mass spectrometry. This literature can help qualified researchers define terminology and evaluate scientific questions. It should not be converted into a claim about the performance or fitness of a commercial vial.

The product-page decision rests on different evidence: a clear 10mg product record, consistent lot labeling, independently generated analytical documentation, and a traceable link to the original report. Keeping scientific background separate from procurement evidence prevents a pathway discussion from being mistaken for a product claim.

Frequently Asked Questions

What does 10mg mean on this SS-31 listing?

It is the labeled content of the vial. It does not state a protocol, dose, concentration, or instruction for use.

Where can the third-party test be reviewed?

The final product-gallery image is the lot-specific COA summary. Its QR code or source link opens the original independent laboratory report.

Can the 30mg or 50mg COA be used for this 10mg product?

No. Each strength and production lot should be matched to its own label and analytical record.

Does the research literature establish the quality of this lot?

No. Literature establishes scientific context. Lot quality and identity are evaluated from the actual product record and the analytical documentation for the released lot.

References

1. Mant et al. (2007): HPLC analysis and purification of peptides.
2. Nolfi-Donegan et al. (2020): Mitochondrial electron transport chain, oxidative phosphorylation, oxidant production, and measurement methods.
3. PubMed: cardiolipin-related SS-31 research.
4. PubMed: mitochondrial bioenergetics research context.
5. FDA: Q2(R2) Validation of Analytical Procedures.
6. FDA: Q14 Analytical Procedure Development.
7. ISO/IEC 17025: Testing and calibration laboratories.
8. NIST: Metrological traceability.

Research Use Notice

This product is sold strictly for in-vitro laboratory research and development purposes only. It is not a drug, food, cosmetic, or dietary supplement and is not intended for human or veterinary use, ingestion, injection, or any form of administration.